Related Experiment Video
Updated: Aug 13, 2026

Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis
Published on: December 8, 2011
Resolution of vulvitis circumscripta plasmacellularis with topical imiquimod: two case reports
H L Ee1, G Yosipovitch, R Chan
1National Skin Centre, 1 Mandalay Road, Singapore 308205, Republic of Singapore. ee_melvin@hotmail.com
Abstract:
Vulvitis circumscripta plasmacellularis (VCP) is a rare but well-described entity. It is notorious for its recalcitrant nature to various modalities of treatment. Intralesional interferon-alpha showed some promise, with complete resolution, but is coupled with the side-effect of myelosuppression. Topical imiquimod is a novel immune response modifier with the ability to induce the production of interferon-alpha. In this paper, we report two cases of VCP whose lesions were resistant to antibiotics, topical and oral corticosteroids, but resolved after a treatment trial with imiquimod.
Related Concept Videos
Acne Infection
Genital Herpes
Candidiasis
Trichomoniasis

